TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biopart AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
260
|
573
|
3,537 |
Financial expenses |
0
![]() |
0
|
4 |
Earnings before taxes |
-315
|
60
|
379 |
EBITDA |
-317
|
60
|
383 |
Total assets |
1,097
|
1,708
|
2,079 |
Current assets |
1,097
|
1,708
|
2,079 |
Current liabilities |
406
|
92
|
443 |
Equity capital |
691
|
1,554
|
1,507 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
1
![]() |
1
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.0%
|
91.0%
|
72.5% |
Turnover per employee |
260
|
573
|
1,768 |
Profit as a percentage of turnover |
-121.2%
|
10.5%
|
10.7% |
Return on assets (ROA) |
-28.7%
|
3.5%
|
18.4% |
Current ratio |
270.2%
|
1856.5%
|
469.3% |
Return on equity (ROE) |
-45.6%
|
3.9%
|
25.1% |
Change turnover |
-313
|
-2,964
|
-1,580 |
Change turnover % |
-55%
|
-84%
|
-31% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.